10 results
Proposed Pathophysiology of COVID19 Lung Injury

COVID19 Lung Injury model schematic based on 1) ACUTE thrombotic vascular
Proposed Pathophysiology ... of COVID19 Lung ... farid__jalali #LungInjury ... #Pathophysiology ... #COVID19 #Pulmonary
Proposed Pathophysiology of COVID19 Lung Injury

My thoughts on COVID19 Lung Injury, centered around 1) ACUTE thrombotic
Proposed Pathophysiology ... of COVID19 Lung ... farid__jalali #LungInjury ... #Pathophysiology ... #COVID19 #Pulmonary
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and Pulmonary Thromboendarterectomy
Chronic Thromboembolic Pulmonary Hypertension
Definition: mean pulmonary-artery pressure > 25mmHg
Thromboembolic Pulmonary ... Thromboembolic Pulmonary ... embolism Pathophysiology ... Bypass Other Treatment ... Thromboendarterectomy #diagnosis #management
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Diagnosis and Management ... Lung Abscess Pathophysiology ... Lung Abscess Management ... Lung #Abscess #pulmonary ... differential #causes #management
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Pathophysiology ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... APML #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Tuberculosis Treatment ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Pathophysiology ... like illnesses, COVID ... Treatment: • Plasmapheresis ... Syndrome #diagnosis #management ... #treatment #neurology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
tuberculosis (LTBI) Pathophysiology ... Tuberculosis Treatment ... Initiating Treatment ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Cryptogenic Organizing Pneumonia - Illness Script

PATHOPHYSIOLOGY: Unknown trigger, reversible inflammatory/fibroproliferative process. Polypoid fibroblastic aggregates that plug
Illness Script PATHOPHYSIOLOGY ... , neoplastic) TREATMENT ... Pneumonia #diagnosis #management ... #pulmonary
Mycoses

HISTOPLASMOSIS
• Inhalation of conidia → Yeast → travel to lymph nodes → spread in body
• Bird
host): • Chronic pulmonary ... Histoplasmosis Treatment ... Mucormycosis Treatment ... Aspergillosis Pathophysiology ... Fungal #Diagnosis #Management